KR101440844B1 - Cosmetic composition with Linum usitatissimum seed mucus or the extract of Linum usitatissimum seed mucus - Google Patents
Cosmetic composition with Linum usitatissimum seed mucus or the extract of Linum usitatissimum seed mucus Download PDFInfo
- Publication number
- KR101440844B1 KR101440844B1 KR1020130053595A KR20130053595A KR101440844B1 KR 101440844 B1 KR101440844 B1 KR 101440844B1 KR 1020130053595 A KR1020130053595 A KR 1020130053595A KR 20130053595 A KR20130053595 A KR 20130053595A KR 101440844 B1 KR101440844 B1 KR 101440844B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- flaxseed
- mucus
- cosmetic composition
- skin
- Prior art date
Links
- 235000004426 flaxseed Nutrition 0.000 title claims abstract description 74
- 210000003097 mucus Anatomy 0.000 title claims abstract description 60
- 239000002537 cosmetic Substances 0.000 title claims abstract description 58
- 239000000203 mixture Substances 0.000 title claims abstract description 52
- 240000006240 Linum usitatissimum Species 0.000 title description 4
- 235000004431 Linum usitatissimum Nutrition 0.000 title description 4
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 claims abstract description 71
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 60
- 210000003491 skin Anatomy 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 229920000715 Mucilage Polymers 0.000 claims description 22
- 239000000853 adhesive Substances 0.000 claims description 22
- 239000006071 cream Substances 0.000 claims description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 15
- 210000002510 keratinocyte Anatomy 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 12
- 230000004069 differentiation Effects 0.000 claims description 11
- 230000008591 skin barrier function Effects 0.000 claims description 11
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 10
- 239000006210 lotion Substances 0.000 claims description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- 229940107657 flaxseed extract Drugs 0.000 claims description 7
- 235000020704 flaxseed extract Nutrition 0.000 claims description 7
- 230000001737 promoting effect Effects 0.000 claims description 7
- 239000000839 emulsion Substances 0.000 claims description 6
- 239000000499 gel Substances 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 4
- 239000000344 soap Substances 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 3
- 239000006072 paste Substances 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 description 26
- 230000000052 comparative effect Effects 0.000 description 18
- 230000000694 effects Effects 0.000 description 18
- 238000002360 preparation method Methods 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- -1 tracant Substances 0.000 description 12
- 235000016709 nutrition Nutrition 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 238000000605 extraction Methods 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 7
- 239000000049 pigment Substances 0.000 description 7
- 239000003755 preservative agent Substances 0.000 description 7
- 230000002335 preservative effect Effects 0.000 description 7
- 210000000434 stratum corneum Anatomy 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229960000458 allantoin Drugs 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 4
- SNPLKNRPJHDVJA-UHFFFAOYSA-N dl-panthenol Chemical compound OCC(C)(C)C(O)C(=O)NCCCO SNPLKNRPJHDVJA-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 description 4
- 239000008158 vegetable oil Substances 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 3
- 229940079894 benzophenone-9 Drugs 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- QDCHWIWENYCPIL-UHFFFAOYSA-L disodium;4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfonatobenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O QDCHWIWENYCPIL-UHFFFAOYSA-L 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 3
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 3
- 229940113124 polysorbate 60 Drugs 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 229950011392 sorbitan stearate Drugs 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 238000000194 supercritical-fluid extraction Methods 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical group C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 108010059892 Cellulase Proteins 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 206010012438 Dermatitis atopic Diseases 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 101710196208 Fibrinolytic enzyme Proteins 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 206010039085 Rhinitis allergic Diseases 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 2
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 201000010105 allergic rhinitis Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 201000008937 atopic dermatitis Diseases 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- UTMTYYKGLQURCK-UHFFFAOYSA-N butane-1,3-diol;propane-1,2,3-triol Chemical compound CC(O)CCO.OCC(O)CO UTMTYYKGLQURCK-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229940106157 cellulase Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 108010093305 exopolygalacturonase Proteins 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 229940068977 polysorbate 20 Drugs 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 2
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- HYZPVMPQJVVJBP-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;propane-1,2,3-triol Chemical compound OCC(O)CO.OCCN(CCO)CCO HYZPVMPQJVVJBP-UHFFFAOYSA-N 0.000 description 1
- CKJGHPBOPQNPHM-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;sodium Chemical compound [Na].OCCN(CCO)CCO CKJGHPBOPQNPHM-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- CGIBWQWAQGGETH-UHFFFAOYSA-N C(CCCCCCC)C(CCCCCCCCCCC)O.N(CCO)(CCO)CCO Chemical compound C(CCCCCCC)C(CCCCCCCCCCC)O.N(CCO)(CCO)CCO CGIBWQWAQGGETH-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 235000001543 Corylus americana Nutrition 0.000 description 1
- 240000007582 Corylus avellana Species 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZIHKFWMIADAWSM-UHFFFAOYSA-N [Na].CC(O)CCO.OCC(O)CO Chemical compound [Na].CC(O)CCO.OCC(O)CO ZIHKFWMIADAWSM-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 230000001461 cytolytic effect Effects 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 235000001916 dieting Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- QAUVAKQRNGDLCF-UHFFFAOYSA-N ethanol;pyridine-3-carboxamide Chemical compound CCO.NC(=O)C1=CC=CN=C1 QAUVAKQRNGDLCF-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 208000024711 extrinsic asthma Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940049294 glyceryl stearate se Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- NEMFQSKAPLGFIP-UHFFFAOYSA-N magnesiosodium Chemical compound [Na].[Mg] NEMFQSKAPLGFIP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000000510 mucolytic effect Effects 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001543 purgative effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 아마씨 점액 또는 점액 추출물을 함유하는 화장료 조성물에 관한 것으로, 피부 보습용 화장료로서 유용하게 사용될 수 있고, 특히 끈적임을 적게 하면서도 퍼짐성, 발림성, 밀착감, 쿠션감 등의 사용성이 우수한 특징이 있다. The present invention relates to a cosmetic composition containing a flaxseed mucus or a mucus extract, and is useful as a cosmetic composition for moisturizing the skin. In particular, it is characterized by excellent usability such as spreadability, spreadability, adhesion feeling and cushion feeling while reducing stickiness.
Description
본 발명은 화장료 조성물에 관한 것으로, 더욱 상세하게는 아마씨 점액 또는 점액 추출물을 함유하는 화장료 조성물에 관한 것이다.
The present invention relates to a cosmetic composition, and more particularly, to a cosmetic composition containing flaxseed mucus or mucus extract.
피부는 외부에서부터 순서대로 표피, 진피, 피하 조직의 3개 층으로 크게 구분되며, 기온 및 습도 변화, 자외선, 기타 물리적, 화학적인 외부 환경의 자극으로부터 체내의 제 기관을 보호해 주는 기능이 있다. 그 중 표피는 인체 내부의 수분증발을 방지하는 중요한 역할을 한다. The skin is largely divided into three layers: epidermis, dermis, and subcutaneous tissue in order from the outside. It protects the internal organs of the body from changes in temperature and humidity, ultraviolet rays, and other physical and chemical external stimuli. Among them, the epidermis plays an important role in preventing water evaporation inside the human body.
표피는 외부로부터 순서대로 각질층, 과립층, 유극층, 기저층으로 구분되며, 각질층의 세포들은 벽돌과 같은 역할을 하고, 각질세포 사이의 세포 간 지질들은 모르타르와 같은 역할로 작용하여 피부 장벽을 구성한다(J. Invest. Dermatol. 80(Suppl.), 44-49. 1983). 건강한 사람의 각질세포에는 고농도의 자연보습인자 (Natural Moisturing Factor, NMF)가 존재하여 피부의 수분 보유를 돕는데, 예를 들면 아미노산과 같은 물질은 수용성이기 때문에 수분과 효과적으로 결합하여 피부 수분이 건조되는 것을 억제한다(J. Invest. Dermatol. 54, 24-31, 1970).The epidermis is divided into the stratum corneum, the granular layer, the superficial layer and the basal layer in order from the outside. Cells of the stratum corneum act as bricks, and the intercellular lipids between the keratinocytes function as mortar to form skin barrier J. Invest. Dermatol 80 (Suppl.), 44-49, 1983). In healthy human keratinocytes, a high concentration of Natural Moisturing Factor (NMF) is present to help maintain moisture in the skin. For example, substances such as amino acids are water-soluble and thus effectively combine with moisture to dry the skin (J. Invest. Dermatol. 54, 24-31, 1970).
한편, 과학의 발달에 따른 산업화로 지구 환경의 급격한 변화가 초래되어 인간 건강에 심각한 영향을 미치게 되었다. 그 결과 각종 만성 및 난치성 질환이 급속히 증가하고 있는데, 전 세계적으로 아토피 피부염, 알레르기 비염, 천식 등과 같은 환경성 질환의 발생 빈도가 많이 증가하는 추세를 보이고 있다. On the other hand, industrialization due to the development of science has caused a drastic change in the global environment, which has had a serious impact on human health. As a result, various chronic and intractable diseases are rapidly increasing, and the incidence of environmental diseases such as atopic dermatitis, allergic rhinitis and asthma is increasing worldwide.
건강보험공단 건강보험연구원이 지난 2002~2007년 동안 건강보험 및 진료비 내역을 분석해 발표한 자료에 따르면, 알레르기 비염, 아토피 피부염, 천식 등 주변 환경오염으로 나타날 수 있는 환경성 질환의 환자가 2002년 552만 명에서 2007년 714만 명(남자 325만 명ㆍ여자 389만 명)으로 29.3% 증가하였는데, 환경성 질환은 2009년 3월부터 ‘녹색건강 프로젝트’를 시작할 정도로 국민 건강과 건강보험 재정에 위협적인 요인으로 떠오르고 있는 실정이다. According to data released by the National Health Insurance Corporation's Health Insurance Research Institute during 2002-2007, the number of patients suffering from environmental diseases such as allergic rhinitis, atopic dermatitis and asthma was estimated to reach 552 million The number of health-related diseases increased by 29.3% from 7.14 million in 2007 to 3.25 million in 2003, and 3.9 million in 2003, .
상기의 환경성 질환을 예방하기 위해서는 피부 보습이 필수적인데, 종래에는 보습제로서 수분을 흡수하는 성질이 있는 휴멕턴트(humectant)나 수분 증발을 방지하는 폐쇄 보습제 (Occlusive Moisturizer)를 사용하여 각질층에서의 수분 보유를 증가시키는 방식이 행하여져 왔다. 휴멕턴트로는 글리세린, 프로필렌글리콜, 1,3-부틸렌글리콜, 폴리에틸렌글리콜, 솔비톨, 2-피롤리돈-5-카르본산나트륨 등의 물질이 있는데, 피부에 도포 시 끈적임이 심하거나 눅진한 느낌이 드는 단점이 있다. 폐쇄 보습제로는 세라마이드 등의 지질 성분이나 필수지방산 및 지질 복합체 등이 있는데(J. Invest. Dermatol. (5), 731-740, 1994), 유화 제형의 안정도를 유지하는데 난점이 있으며, 투명한 젤 상의 제품을 제조하는 데 부적합한 단점이 있다.In order to prevent the aforementioned environmental diseases, skin moisturization is indispensable. In the past, humectants having moisture-absorbing properties and Occlusive Moisturizers preventing evaporation of water have been used, and moisture content in the stratum corneum Has been performed. Examples of humectant include glycerin, propylene glycol, 1,3-butylene glycol, polyethylene glycol, sorbitol, 2-pyrrolidone-5-carboxylate and the like. This drawback has its drawbacks. (5), 731-740, 1994), there is a difficulty in maintaining the stability of the emulsified formulations, and there is a problem in that a transparent gel phase There is a disadvantage that it is not suitable for manufacturing a product.
그런데, 최근 각질층의 분화가 피부수분의 건조를 막는데 중요하다는 주장이 제기되었다. 기저층의 각질형성세포에서 최외곽 각질층의 각질세포로 발달되는 분화과정이 정상적으로 행해져야 피부 수분 보유장벽으로서의 역할을 할 수 있다는 사실이 밝혀진 것이다. 즉, 각화의 과정 중 세포는 자연보습인자와 세포간 지질을 생성하게 되고, 그 결과 각질층은 견고하고 유연하게 되어 방어벽으로서의 기능을 할 수 있게 된다는 것이다. 사람의 연령이 증가되면서 피부가 건조해지는 경향을 생리적으로 보면, 각질층의 탈락 시간이 길어지거나 표피세포의 지질 합성능력이 저하되고, 피부 각질층의 보습인자와 지질의 양이 감소되는 것으로 해석할 수 있다. 그러므로, 각질형성세포의 분화를 촉진시킴으로써 피부 장벽의 강화를 유도하여 피부 수분 유지 기능과 외부 환경으로부터의 보호기능을 증진시킬 수 있는 새로운 접근 방법이 타당한 것이라 할 수 있는 것이다. However, recently it has been argued that the differentiation of the stratum corneum is important in preventing the drying of skin moisture. It has been found that the differentiation process developed from the keratinocytes of the basal layer to the keratinocytes of the outermost keratinocyte can function as a barrier to skin moisture retention. In other words, during the process of keratinization, the cells produce natural moisturizing factors and intercellular lipids, and as a result, the stratum corneum becomes rigid and supple, allowing it to function as a barrier. Physiological tendency of the skin to become dry as the age of the human is increased can be interpreted as a longer time for the removal of the stratum corneum, a lowering of the lipid synthesis ability of the epidermal cells, and a decrease in the amount of the moisturizing factor and lipid in the stratum corneum . Therefore, it is reasonable to propose a new approach to promote the differentiation of keratinocytes to induce strengthening of skin barrier, thereby enhancing skin moisture retaining function and protection from external environment.
한편, 아마는 1년생초본으로 초장은 70~110cm이며 줄기의 굵기는 1~2mm 내외이다. 아마에는 각종 영양 물질의 많이 함유되어 있고, 이로 말미암아 뛰어난 기능성을 발휘할 수 있는 소재의 근원이 될 수 있는데, 소화 상 문제 등 많은 이유로 그 활용이 매우 한정되고 있는 실정이다. On the other hand, flax is a one-year-old herb with a plant height of 70 ~ 110cm and a stem diameter of about 1 ~ 2mm. The flaxseed contains a lot of various nutrients, which can be a source of materials that can exert excellent functionality. However, its application is very limited for many reasons such as problems with digestion.
아마씨에는 점액질의 성분이 함유되어 있는데, 이 부분이 섭취시 소화를 방해하거나 흡수성이 낮게 할 수 있다는 점에 착안하여, 아마를 다이어트 식품에 이용하려고 하는 노력이 많이 있어 왔다. 아마 점액에 대한 설명은 대한민국 등록특허(10-1239432)에 잘 기술되어 있다. Flaxseed contains mucolytic components, and it has been a lot of effort to use flax as food for dieting, considering that this part can interfere with digestion or lower the absorbability of this part. Perhaps the description of mucus is well described in the Korean Registered Patent (10-1239432).
한편, 아마를 보호하고 있는 이들 점액질을 분리하여, 다른 용도로 사용하려는 노력은 대한민국 등록특허 제10-1239432호 등에 많이 있어 왔으나, 이를 이용한 화장품 조성물에 대한 연구는 미미한 실정이었다.
On the other hand, Korean Patent No. 10-1239432 has been widely used for separating and protecting flax-protecting mucus from other uses, but the research on the cosmetic composition using such mucolipids has been limited.
화장품은 소비자들의 선택적 기호 제품이기 때문에 향취, 사용감, 용기 등의 감성과 기능성 등의 과학을 결합한 요소가 매우 중요시되는 산업분야이다. 여러 가지 원료가 조합되는 화장품 제품의 특성상 사용감은 특히 중요하게 고려되어야 하는데, 사용감에 미치는 주요 인자로는 퍼짐심, 발림성, 촉촉함, 끈적임, 쿠션감 등이 있다. Since cosmetics are a preference product of consumers, it is an industrial field that combines science such as sensitivity, feeling, and courage such as sensibility and functionality. The feeling of use should be considered particularly important due to the nature of the cosmetic product in which various raw materials are combined. The main factors affecting the sensation of use are spreading, spreading, moisturizing, stickiness and cushioning.
화장품 연구자들이 사용감을 증대시키기 위해 지속적으로 노력하고 있으나 여러 가지 원료가 혼합되는 화장품의 특성상 그리 용이한 것은 아니다. 퍼짐성, 발림성, 밀착감, 퍼점성, 쿠션감 등의 사용성을 증가시키고자 하면, 거의 대부분의 경우에서 끈적임이 증가하는 문제가 발생한다. Cosmetics researchers are continuously trying to increase the feeling of use, but it is not easy to make cosmetics with various ingredients mixed. There is a problem that the stickiness increases in almost all cases when the usability such as spreadability, spreadability, adhesion feeling, fogging property and cushion feeling is increased.
따라서, 끈적이지 않으면서도 퍼짐성, 발림성, 쿠션감 등에 대해 우수한 효능을 발휘할 수 있는 소재의 개발이 요구되는데, 본 발명에서는 이와 같은 소재를 개발하여 제공하고자 한다.
Therefore, development of a material capable of exhibiting excellent efficacy against spreadability, spreadability, cushioning, etc. without stickiness is required. In the present invention, such a material is developed and provided.
본 발명은 아마씨 점액 또는 점액 추출물을 유효성분으로 함유하는 것을 특징으로 하는 화장료 조성물을 제공한다. 본 발명의 화장료 조성물에 있어서, 상기 화장료 조성물은 일 예로 피부 각질형성세포 분화 촉진용, 피부 장벽기능 회복용, 피부보습용, 사용감 개선용일 수 있다. The present invention provides a cosmetic composition characterized by containing flaxseed mucus or mucus extract as an active ingredient. In the cosmetic composition of the present invention, the cosmetic composition may be, for example, for promoting the differentiation of dermal keratinocytes, for restoring skin barrier function, for skin moisturizing, and for improving feeling.
한편, 본 발명의 화장료 조성물에 있어서, 상기 아마씨 점액 또는 점액 추출물은, 일 예로, 화장료 조성물 총 중량에 대하여 0.001 내지 100.0중량% 함유될 수 있다. Meanwhile, in the cosmetic composition of the present invention, the flaxseed mucus or mucus extract may be contained in an amount of, for example, 0.001 to 100.0% by weight based on the total weight of the cosmetic composition.
한편, 본 발명의 화장료 조성물에 있어서, 상기 아마씨 점액 추출물은, 일 예로, (a) 물, 탄소수 1~4의 무수 또는 함수 저급 알코올, 아세톤, 에틸 아세테이트, 클로로포름, 부틸아세테이트 및 1,3-부틸렌 글리콜로 구성된 군으로부터 선택되는 추출용매를 아마씨에 가하여 추출한 점액추출물, (b) 초음파를 아마씨에 가하여 추출한 점액추출물 및 (c) 초임계 용매를 아마씨에 가하여 추출한 점액추출물 중 선택되는 어느 하나인 것일 수 있다. In the cosmetic composition of the present invention, for example, the flaxseed mucus extract may be prepared by mixing (a) water, an anhydrous or hydrous lower alcohol having 1 to 4 carbon atoms, acetone, ethyl acetate, chloroform, butyl acetate and 1,3- (B) a mucus extract obtained by adding ultrasonic waves to flaxseed extract, and (c) a mucus extract obtained by adding a supercritical solvent to flaxseed extract, wherein the extract is selected from the group consisting of .
한편, 본 발명의 화장료 조성물에 있어서, 상기 화장료 조성물은, 일 예로 수용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이로 구성된 군으로부터 선택되는 어느 하나의 제형일 수 있다. Meanwhile, in the cosmetic composition of the present invention, the cosmetic composition may be an aqueous solution, a suspension, an emulsion, a paste, a gel, a cream, a lotion, a powder, a soap, a surfactant-containing cleansing oil, a powder foundation, , A wax foundation, and a spray.
본 발명을 통해, 아마씨 점액 또는 점액 추출물에 피부 각질형성세포의 분화를 촉진하고, 피부 장벽기능을 회복시키며, 피부의 당김, 거칠음을 해소하고, 탄력을 증가시키는 효과가 있음이 확인되었다. Through the present invention, it was confirmed that flaxseed mucus or mucus extract promotes differentiation of dermal keratinocytes, restores skin barrier function, relieves skin pulling and roughness, and increases elasticity.
따라서, 본 발명의 아마씨 점액 또는 추출물은 화장료 조성물에 첨가되어 사용될 수 있는데, 피부 보습용 화장료로서 유용하게 사용될 수 있고, 특히 끈적임을 적게 하면서도 퍼짐성, 발림성, 밀착감, 쿠션감 등의 사용성이 우수한 특징이 있다.
Therefore, the flaxseed mucus or extract of the present invention can be used as a cosmetic composition for skin moisturizing, and can be effectively used as a cosmetic composition for skin moisturizing. Particularly, it has excellent properties such as spreadability, spreadability, have.
본 발명의 화장료 조성물에 포함되는 아마씨 점액 또는 점액 추출물은 지금까지 알려지지 않은 조성의 펙틴-유사(pectin-like) 물질을 함유하고 있는데, 이 물질의 역할은 동물의 소화관을 통해 지나가는 씨앗을 보호하여 이들이 생존을 유지할 수 있게 한다. 인간 소화관도 동물과 유사하게 미가공, 미처리된 아마 씨앗을 소화시킬 수 없다. The flaxseed mucilage or mucus extract contained in the cosmetic composition of the present invention contains a pectin-like substance of a heretofore unknown composition. The role of this substance is to protect the passing seeds through the digestive tract of an animal, It can keep survival. Human digestive tracts can not digest untreated, untreated flaxseeds similar to animals.
1kg의 아마씨는 5리터의 물을 결합할 수 있고, 그 결과 위액이 씨앗 껍질의 표면에 도달할 수 없게 하는데, 이 미끄러운 겔-유사 물질은 창자의 활동을 현저하게 향상시키고, 수많은 경우에 변통 물질(purgative substance)로서 기능한다. 게다가, 아마씨의 점액질은 소화를 방해하는 많은 물질, 예컨대, 하이드로시아나이드(hydrocyanids) 및 트립신 억제제를 포함하는 것으로 알려져 있다. 비록 열처리에 의해 이들의 영향이 감소될 수 있지만, 이들의 방해효과가 완전히 제거될 수는 없다는 보고가 있다(Journal of the American Oil Chemists' Society 70(9): 899-904, 1993).One kilogram of flaxseed can combine 5 liters of water, resulting in the gastric juice being unable to reach the surface of the seed coat. This slippery gel-like material significantly improves bowel activity and, in many cases, (purgative substance). In addition, flaxseed mucilage is known to contain many substances that interfere with digestion, such as hydrocyanids and trypsin inhibitors. Although these effects can be reduced by heat treatment, there is a report that their interference effects can not be completely eliminated (Journal of the American Oil Chemists' Society 70 (9): 899-904, 1993).
본 발명에서는 상기와 같은 특징이 있는 아마씨 점액 또는 점액 추출물을 이용하여 화장료 조성물로서의 유용성을 확인한 후, 화장료 조성물의 유효성분으로 제공하고자 한다. 본 발명의 아마씨 점액은 아마씨로부터 긁어내는 등의 물리적 탈리 방법에 의해 수득될 수도 있고, 업계에 공지된 통상의 방법에 따라 즉, 통상적인 온도와 압력의 조건 하에서, 통상적인 용매를 사용하여 아마씨로부터 추출물의 형태로 수득될 수도 있다.In the present invention, the use of flaxseed mucilage or mucus extract having the above-mentioned characteristics is intended to provide an effective ingredient of a cosmetic composition after confirming its usefulness as a cosmetic composition. The flaxseed mucus of the present invention may be obtained by a physical desorption method such as scraping from flaxseed and may be carried out by a conventional method known in the art, that is, under the conditions of ordinary temperature and pressure, May also be obtained in the form of an extract.
일 예로, 본 발명의 아마씨 점액 추출물은 정제수, 메탄올, 에탄올, 글리세린, 에틸아세테이트, 부틸렌글리콜, 프로필렌글리콜, 디클로로메탄, 클로로포름, 에틸에테르, 부틸렌글라이콜 및 헥산으로 구성된 군으로부터 선택된 1종 이상의 추출용매를 사용하여 추출될 수 있으며, 바람직하게는 에탄올, 70% 에탄올 또는 물을 사용하여 추출되며, 보다 바람직하게는 70% 에탄올을 사용하여 추출될 수 있다. 본 발명의 아마씨 점액추출물은 상기한 추출 용매뿐만 아니라, 다른 추출 용매를 이용하여도 실질적으로 동일한 효과를 나타내는 추출물이 얻어질 수 있다는 것은 당업자에게 자명한 것이다.For example, the flaxseed mucus extract of the present invention may be at least one selected from the group consisting of purified water, methanol, ethanol, glycerin, ethyl acetate, butylene glycol, propylene glycol, dichloromethane, chloroform, ethyl ether, butyleneglycol, Can be extracted using an extraction solvent, preferably extracted using ethanol, 70% ethanol or water, more preferably 70% ethanol. It is obvious to those skilled in the art that the extract of flaxseed mucus of the present invention can be obtained not only by the above-mentioned extraction solvent but also by using other extraction solvent, which exhibits substantially the same effect.
또한, 상기의 일반적 추출법 외에 초임계 추출용매를 이용한 초임계 추출법 또는 초음파를 가하는 초음파 추출법을 사용하여 아마씨로부터 아마씨 점액 추출물을 제조할 수도 있다. 초임계 추출법 및 초음파 추출법에 관한 세부적 과정은 이미 널리 알려져 있기 때문에 이에 관한 구체적인 기재는 생략하기로 한다. In addition to the general extraction method described above, supercritical extraction using a supercritical extraction solvent or ultrasonic extraction using ultrasonic waves may be used to produce a flaxseed mucus extract from flaxseed. Since the detailed processes of the supercritical extraction method and the ultrasonic extraction method are already well known, detailed description thereof will be omitted.
한편, 본 발명의 아마씨 점액 추출물은 상술한 추출 용매에 의한 추출물뿐만 아니라, 통상적인 정제 과정을 거친 추출물도 포함한다. 예컨대, 일정한 분자량 컷-오프 값을 갖는 한외 여과막을 이용한 분리, 다양한 크로마토그래피 (크기, 전하, 소수성 또는 친화성에 따른 분리를 위해 제작된 것)에 의한 분리 등, 추가적으로 실시된 다양한 정제 방법을 통해 얻어진 활성 분획도 본 발명의 추출물에 포함되는 것이다. On the other hand, the flaxseed mucus extract of the present invention includes not only the extract obtained by the above-mentioned extraction solvent, but also the extract obtained through a usual purification process. For example, by separation using an ultrafiltration membrane having a constant molecular weight cut-off value, separation by various chromatographies (made for separation by size, charge, hydrophobicity or affinity), and the like, The active fraction is also included in the extract of the present invention.
또한, 본 발명의 아마씨 점액 추출물은, 아마씨 점액 추출물을 상온에서 냉침 또는 가열한 후, 여과하여 얻어진 액상물일 수 있고, 감압 농축 또는 동결건조하여 얻은 것일 수도 있다.In addition, the flaxseed mucus extract of the present invention may be a liquid obtained by cooling or heating the flaxseed mucus extract at room temperature, followed by filtration, and may be obtained by concentration under reduced pressure or lyophilization.
한편, 본 발명에서 아마씨 점액은 다음과 같은 효소 용액으로 발효 및 배양시켜 제조될 수도 있다. 효소 용액으로는 펙틴분해효소 또는 섬유소분해효소가 첨가된 효소 용액을 사용할 수 있는데, 선택적으로 단백질분해효소를 함유할 수도 있다. 펙틴분해효소로서는 펙티나아제( Macerozyme R-10 등), 섬유소분해효소로서는 셀룰라아제(Onozuka R-10 등), 단백질분해효소로서는 프로테아제 등이 사용될 수 있다. 아마씨를 통상 자기 부피비의 1배에서 수배, 바람직하게는 2배의 물을 가한 후 상기 효소를 첨가하고 20~40℃, 바람직하게는 25~37℃에서, 2~24시간 동안 바람직하게는 6~12시간 동안 배양할 수 있다.Meanwhile, in the present invention, the flaxseed mucus may be prepared by fermentation and cultivation with the following enzyme solution. As the enzyme solution, an enzyme solution to which a pectin-degrading enzyme or a fibrinolytic enzyme is added may be used, and optionally, a proteolytic enzyme may be contained. Examples of the pectin-degrading enzyme include pectinase (Macerozyme R-10 and the like), cellulolytic enzyme such as cellulase (Onozuka R-10 and the like), protease as protease and the like. The enzyme is added to the flaxseed usually at a ratio of 1 to several times, preferably 2 times, the volume of the magnetic volume, and the enzyme is added thereto at 20 to 40 캜, preferably 25 to 37 캜, for 2 to 24 hours, It can be cultured for 12 hours.
한편, 본 발명에서 아마씨 점액질 또는 점액 추출물의 분리 또는 여과는 통상적인 여과장치 예컨대, 와트만 여과지, 100~400메쉬 등이 부착된 여과장치, 감압여과장치 등을 이용하거나, 물리적인 힘(원심력, 중력)에 의한 교반 및 회전 등의 방법을 이용할 수 있다.Meanwhile, in the present invention, the separation or filtration of flaxseed mucilage or mucus extract can be carried out by using a conventional filtration device such as a Wattmann filter paper, a filtration device with 100 to 400 mesh or the like, a vacuum filtration device, Stirring and rotation by gravity) can be used.
한편, 본 발명의 아마씨 점액 또는 점액 추출물은 화장료 조성물 전체에 대해서 0.001~100.0중량% 함유될 수 있으며, 바람직하게는 0.1~60.0중량% 함유될 수 있는데, 가장 바람직하게는 0.1~30.0중량% 함유될 수 있다. 아마씨 점액 또는 점액 추출물의 함량이 0.001중량% 미만인 경우에는 피부개선 효과가 나타나지 않기 때문다.On the other hand, the flaxseed mucus or mucus extract of the present invention may be contained in an amount of 0.001 to 100.0% by weight, preferably 0.1 to 60.0% by weight, and most preferably 0.1 to 30.0% by weight, . When the content of flaxseed mucilage or mucus extract is less than 0.001% by weight, the skin improvement effect is not exhibited.
본 발명에 따르면, 본 발명의 아마씨 점액 또는 점액 추출물은 피부 각질형성 세포 분화 촉진 효과, 피부장벽 기능 회복 효과, 보습효과 및 사용감 개선효과가 뛰어난데, 본 발명의 화장료 조성물은 유효성분인 아마씨 점액 또는 점액추출물 외에 화장품 조성물에 통상적으로 이용되는 성분들을 포함하며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함할 수 있다.According to the present invention, the flaxseed mucilage or mucus extract of the present invention is excellent in skin keratinocyte differentiation promoting effect, skin barrier function restoration effect, moisturizing effect and feeling improving effect. The cosmetic composition of the present invention is an effective ingredient, In addition to the mucus extract, it may contain the components conventionally used in cosmetic compositions, and may include customary adjuvants such as antioxidants, stabilizers, solubilizers, vitamins, pigments and flavors, and carriers.
본 발명의 화장료 조성물은 당 업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있는데, 반드시 이에 한정되는 것은 아니다. 보다 상세하게는, 유연 화장수, 영양 화장수, 영양 크림, 마사지 크림, 에센스, 아이 크림, 클렌징 크림, 클렌징 포옴, 클렌징 워터, 팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다. The cosmetic composition of the present invention can be prepared into any of the formulations conventionally produced in the art and can be used in the form of solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, soaps, , Oil, powder foundation, emulsion foundation, wax foundation, and spray, but the present invention is not limited thereto. More specifically, it can be manufactured in the form of a soft lotion, a nutritional lotion, a nutritional cream, a massage cream, an essence, an eye cream, a cleansing cream, a cleansing foam, a cleansing water, a pack, a spray or a powder.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, an animal oil, vegetable oil, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as the carrier component .
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.In the case where the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. In the case of a spray, a mixture of chlorofluorohydrocarbons, propane / Propane, such as butane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예로서 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or an emulsion, a solvent, a dissolving agent or an emulsifying agent is used as a carrier component, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, 1,3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid esters of sorbitan.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소 결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.In the case where the formulation of the present invention is a suspension, a carrier such as water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Cellulose, aluminum metahydroxide, bentonite, agar or tracant, etc. may be used.
본 발명의 제형이 계면-활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is an interfacial active agent-containing cleansing, the carrier component is selected from aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate, fatty acid amide Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives or ethoxylated glycerol fatty acid esters.
한편, 본 발명은 본 발명의 아마씨 점액추출물을 함유하는 화장료 조성물을 인간의 피부에 도포하는 것을 특징으로 하는 화장 방법을 제공하기도 한다. 본 발명의 화장 방법은 본 발명의 화장료 조성물을 인간의 피부에 도포하는 모든 화장 방법을 포함한다. 즉, 화장료 조성물을 피부에 도포하는 당업계에 공지된 모든 방법이 본 발명의 화장 방법에 속하는 것이다.On the other hand, the present invention also provides a cosmetic method characterized by applying a cosmetic composition containing the extract of flaxseed mucus of the present invention to human skin. The cosmetic process of the present invention includes all cosmetic processes for applying the cosmetic composition of the present invention to human skin. That is, all methods known in the art for applying the cosmetic composition to the skin belong to the cosmetic method of the present invention.
본 발명의 화장료 조성물은 단독 또는 중복 도포하여 사용하거나, 본 발명 이외의 다른 화장료 조성물과 중복 도포하여 사용할 수도 있다. 또한, 본 발명의 화장료 조성물은 통상적인 사용방법에 따라 사용될 수 있으며, 사용자의 피부 상태 또는 취향에 따라 사용 횟수를 달리할 수도 있다. 본 발명의 화장료 조성물이 비누, 계면활성제 함유 클렌징 또는 계면활성제 비함유 클렌징 제형일 경우, 피부에 도포한 후 닦아내거나 떼거나 물로 씻어낼 수도 있다. 구체적인 예로서, 상기 비누는 액상비누, 가루비누, 고형비누 및 오일비누이며, 상기 계면활성제 함유 클린징 제형은 클렌징폼, 클렌징 워터, 클렌징 수건 및 클렌징 팩이며, 상기 계면활성제 비함유 클렌징 제형은 클렌징크림, 클렌징 로션, 클렌징 워터 또는 클렌징 겔인데, 반드시 이에 한정되는 것은 아니다.The cosmetic composition of the present invention may be used alone or in combination, or it may be used after being overlapped with other cosmetic compositions other than the present invention. In addition, the cosmetic composition of the present invention can be used according to a conventional method of use, and the number of times of use may be varied depending on the skin condition or taste of the user. When the cosmetic composition of the present invention is a soap, a surfactant-containing cleansing agent, or a surfactant-free cleansing agent, it may be applied to the skin and then wiped off or removed or washed with water. The surfactant-containing cleansing formulation is a cleansing foam, a cleansing water, a cleansing towel, and a cleansing pack. The surfactant-free cleansing formulation may be a cleansing cream, , A cleansing lotion, a cleansing water or a cleansing gel, but is not limited thereto.
본 발명의 아마씨 점액추출물을 포함하는 화장료 조성물을 인간의 피부에 도포하는 화장방법을 수행하면, 피부 각질형성세포 분화 촉진 효과, 피부 장벽기능 회복 효과 및 피부보습 효과를 얻을 수 있다.
When the cosmetic composition comprising the extract of flaxseed mucus of the present invention is applied to human skin, it is possible to obtain a skin keratinocyte differentiation promoting effect, a skin barrier function restoration effect, and a skin moisturizing effect.
이하 본 발명의 내용을 하기 실시예를 통하여 더욱 상세히 설명하고자 한다. 다만, 본 발명의 권리범위가 하기 실시예에만 한정되는 것은 아니고, 이와 등가의 기술적 사상의 변형까지를 포함한다.
Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the scope of the present invention is not limited to the following embodiments, and includes modifications of equivalent technical ideas.
[[ 제조예Manufacturing example 1: 아마씨 점액 추출물의 제조] 1: Preparation of flaxseed mucus extract]
아마씨 10.0g을 정제수 500ℓ에 넣고, 25℃에서 5시간 동안 교반 후, 300메쉬 여과포로 여과하였다. 이후, 이 여액에 동량의 알콜을 첨가하여 침전을 시킨 후 와트만 여과지 No. 5로 여과한 후, 건조하여 백색의 파우더 약 0.45g을 얻었다.
10.0 g of flaxseed was put into 500 L of purified water, stirred at 25 DEG C for 5 hours, and then filtered through a 300-mesh filter cloth. Thereafter, an equal amount of alcohol was added to the filtrate to precipitate. 5, and then dried to obtain about 0.45 g of a white powder.
[[ 제조예Manufacturing example 2: 아마씨 점액 추출물의 제조] 2: Preparation of mucilage mucus extract]
아마씨 10.0g을 정제수 500ℓ에 넣고, 25℃에서 5시간 동안 교반 후 300메쉬 여과포로 여과하였다. 이후, 여과한 액을 -48℃, 0.1toor 조건에서 동결건조하여 백색의 파우더 약 0.5g을 얻었다.
10.0 g of flaxseed were placed in 500 L of purified water, stirred at 25 캜 for 5 hours, and then filtered with a 300-mesh filter cloth. Thereafter, the filtrate was lyophilized under the conditions of -48 캜 and 0.1 toor to obtain about 0.5 g of a white powder.
[[ 제조예Manufacturing example 3: 아마씨 점액추출물의 제조] 3: Preparation of flaxseed mucus extract]
아마씨 10.0g에 정제수 500g을 가한 후 펙티나아제(Macerozyme R-10), 섬유소분해효소로서 셀룰라아제(Onozuka R-10)를 각각 100unit 가한 후 37℃에서 12시간 배양시켰다. 이후, 점액질을 300메쉬 여과포로 여과하였다. 이후, 여과한 액을 -48℃, 0.1toor 조건에서 동결건조하여 백색의 파우더 약 0.5g을 얻었다.
After adding 500 g of purified water to 10.0 g of flaxseed, 100 ng of pectinase (Macerozyme R-10) and 10 g of cellulase (Onozuka R-10) as a fibrinolytic enzyme were added, followed by incubation at 37 ° C for 12 hours. Then, the mucous layer was filtered with 300 mesh filter cloth. Thereafter, the filtrate was lyophilized under the conditions of -48 캜 and 0.1 toor to obtain about 0.5 g of a white powder.
[[ 제조예Manufacturing example 4: 아마씨 점액 추출물의 제조] 4: Preparation of mucilage mucus extract]
아마씨 10g을 물 1.2ℓ에 넣고 65℃에서 5시간 동안 추출한 후, 300메쉬 여과포로 여과하고, 4℃에서 5일간 방치하여 숙성시킨 후 와트만 5번 여과지로 여과하였다. 이 여액을 65℃에서 회전 감암 증발기로 건조하여, 건조 중량 0.83g을 얻었다.
10 g of flaxseed was put into 1.2 L of water and extracted at 65 DEG C for 5 hours. Then, the mixture was filtered through a 300-mesh filter cloth, allowed to stand at 4 DEG C for 5 days, aged, and then filtered through Wattman filter paper No. 5. The filtrate was dried at 65 ° C with a rotary attenuator to obtain 0.83 g of dry weight.
[[ 제조예Manufacturing example 5~22: 아마씨 점액 추출물의 제조] 5 ~ 22: Preparation of flaxseed mucus extract]
물 대신 하기 표 1의 추출용매를 사용하는 것을 제외하고는 제조예 4에서와 동일한 방법으로 아마씨를 추출하여 제조예 5~22의 아마씨 점액추출물을 얻었다.The flaxseed extract of Preparation Examples 5 to 22 was obtained by extracting flaxseed in the same manner as in Production Example 4, except that the extraction solvent of Table 1 was used in place of water.
(단위 : g)Dry weight of final extract
(Unit: g)
[제조예 23: 아마씨 점액의 제조][Preparation Example 23: Preparation of flaxseed slurry]
스크래퍼(scraper)를 이용하여 아마씨로부터 점액질을 긁어내어 아마씨 점액 10g을 얻었다.
The sclera was used to scrape mucus from flaxseed to obtain 10 g of flaxseed mucilage.
[[ 실험예Experimental Example 1: 각질형성세포 분화 촉진 효과] 1: promoting effect of keratinocyte differentiation]
사람의 각질형성세포를 배양용 플라스크에 넣고 배양하여 약 80% 정도로 성장시킨 후, 하기 표 2와 같이 아마씨 점액 추출물(제조예 2)을 각각 10, 50, 100, 200ppm 농도로 첨가하여 4일간 처리한 다음, 요소(urea)나 SDS(sodium dodecyl sulfate) 같은 변성제 및 β-머캅토에탄올(β-mercaptoethanol) 같은 환원제를 혼합하여 용해되는 단백질을 제거하였다. 그 후, 남은 각질층을 310㎚에서의 흡광도를 측정하여 펩타이드 농도를 분석하였으며, 음성대조군인 증류수를 기준(0%)으로 각 시료에 의한 증가량을 비교하였다. 이때, 양성대조군으로 TGF-β 10nM를 처리하였다.Human keratinocytes were cultured in a culture flask and grown to about 80%. The flaxseed mucus extract (Preparation Example 2) was added at concentrations of 10, 50, 100, and 200 ppm, respectively, Then, the protein was dissolved by mixing a urea, a denaturant such as sodium dodecyl sulfate (SDS), and a reducing agent such as? -Mercaptoethanol. After that, the remaining horny layer was measured for absorbance at 310 nm to analyze the peptide concentration, and the amount of increase by each sample was compared with that of distilled water as a negative control (0%). At this time, TGF-β 10 nM was treated as a positive control.
상기 표 1의 결과에서 보는 바와 같이, 본 발명에 사용된 아마씨 점액 추출물의 각질형성세포 분화촉진효과가 매우 우수함을 확인할 수 있었다.
As can be seen from the results of Table 1, it was confirmed that the flaxseed mucus extract used in the present invention has an excellent effect of promoting keratinocyte differentiation.
[[ 처방예Prescription example 1: 유연화장수] 1: softening longevity]
화장료의 일 예로, 제조예 2의 아마씨 점액 추출물을 함유한 유연화장수를 처방하였는데, 그 조성은 하기 표 3와 같았다.As an example of the cosmetic material, the softening longevity containing the flaxseed extract of Preparation Example 2 was prescribed, and the composition was as shown in Table 3 below.
글리세린
1.3-부틸렌글리콜
피이지1500
알란토인
DL-판테놀
이.디.티.에이-2NA
벤조페논-9
소듐 히아루로네이트
에탄올
옥틱도데세스-16
폴리솔베이트 20
방부제, 향, 색소
증류수Flaxseed mucus extract
glycerin
1,3-butylene glycol
PIZZY 1500
Allantoin
DL-Panthenol
Lee D. TEE-2NA
Benzophenone-9
Sodium hyaruronate
ethanol
Octidodeces-16
Polysorbate 20
Preservative, fragrance, pigment
Distilled water
5.0
3.0
1.0
0.1
0.3
0.02
0.04
5.0
10.0
0.2
0.2
미량
잔량10.0
5.0
3.0
1.0
0.1
0.3
0.02
0.04
5.0
10.0
0.2
0.2
a very small amount
Balance
[[ 처방예Prescription example 2: 수렴화장수] 2: convergent lotion]
화장료의 일 예로, 제조예 2의 아마씨 점액 추출물을 함유한 수렴화장수를 처방하였는데, 처방예는 하기 표 4와 같았다.As an example of the cosmetic material, a convergent lotion containing the extract of flaxseed mucilage of Preparation Example 2 was prescribed. The prescription examples are shown in Table 4 below.
글리세린
1.3-부틸렌글리콜
알란토인
DL-판테놀
EDTA-2Na
벤조페논-9
소듐 히아루로네이트
에탄올
폴리솔베이트 20
위치하젤 추출물
구연산
방부제, 향, 색소
증류수Flaxseed mucus extract
glycerin
1,3-butylene glycol
Allantoin
DL-Panthenol
EDTA-2Na
Benzophenone-9
Sodium hyaruronate
ethanol
Polysorbate 20
Location of Hazel extract
Citric acid
Preservative, fragrance, pigment
Distilled water
2.0
2.0
0.2
0.2
0.02
0.04
3.0
15.0
0.3
2.0
미량
미량
잔량30.0
2.0
2.0
0.2
0.2
0.02
0.04
3.0
15.0
0.3
2.0
a very small amount
a very small amount
Balance
[[ 처방예Prescription example 3: 영양화장수] 3: Nourishing lotion]
화장료의 일 예로서, 제조예 2의 아마씨 점액 추출물을 함유한 영양화장수를 처방하였는데, 처방예는 하기 표 5와 같았다.As an example of the cosmetic, a nutritional lotion containing the extract of flaxseed mucilage of Preparation Example 2 was prescribed. The prescription examples were as shown in Table 5 below.
글리세릴 스테아레이트SE
스테아릴 알콜
라놀린
폴리솔베이트 60
솔비탄스테아레이트
경화식물유
광물유
스쿠알란
트리옥타노인
디메치콘
초산토코페롤
카르복시비닐폴리머
글리세린
1.3-부틸렌글리콜
소듐히아루로네이트
트리 에탄올아민
방부제, 향, 색소
증류수Flaxseed mucus extract
Glyceryl stearate SE
Stearyl alcohol
lanolin
Polysorbate 60
Sorbitan stearate
Hardened vegetable oil
Mineral oil
Squalane
Trioctanoin
Dimethicone
Tocopheryl acetate
Carboxyvinyl polymer
glycerin
1,3-butylene glycol
Sodium hyaruronate
Triethanolamine
Preservative, fragrance, pigment
Distilled water
1.5
1.5
1.5
1.3
0.5
1.0
5.0
3.0
2.0
0.8
0.5
0.12
5.0
3.0
5.0
0.12
미량
잔량50.0
1.5
1.5
1.5
1.3
0.5
1.0
5.0
3.0
2.0
0.8
0.5
0.12
5.0
3.0
5.0
0.12
a very small amount
Balance
[[ 처방예Prescription example 4: 영양크림] 4: nutrition cream]
화장료의 일 예로서, 제조예 2의 아마씨 점액 추출물을 함유한 영양크림을 처방하였는데, 처방예는 하기 표 6과 같았다.As an example of the cosmetic material, a nutritional cream containing the extract of flaxseed mucilage of Preparation Example 2 was used, and the prescription examples were as shown in Table 6 below.
1,3-부틸렌글라이콜
친유형 모노스테아린산글리세린
세테아릴알콜
스테아린산
밀납
폴리솔베이트 60
솔비탄스테아레이트
경화식물유
스쿠알란
광물유
트리옥타노인
디메치콘
소듐마그네슘실리케이트
글리세린
베타인
트리에타올아민
소듐히아루로네이트
방부제, 향, 색소
증류수Flaxseed mucus extract
1,3-butylene glycol
Pro-type glycerin monostearate
Cetearyl alcohol
Stearic acid
Wax
Polysorbate 60
Sorbitan stearate
Hardened vegetable oil
Squalane
Mineral oil
Trioctanoin
Dimethicone
Sodium magnesium silicate
glycerin
Betaine
Triethanolamine
Sodium hyaruronate
Preservative, fragrance, pigment
Distilled water
-
2.0
2.2
1.5
1.0
1.5
0.6
1.0
3.0
5.0
5.0
1.0
0.1
5.0
3.0
1.0
4.0
미량
잔량5.0
-
2.0
2.2
1.5
1.0
1.5
0.6
1.0
3.0
5.0
5.0
1.0
0.1
5.0
3.0
1.0
4.0
a very small amount
Balance
-
2.0
2.2
1.5
1.0
1.5
0.6
1.0
3.0
5.0
5.0
1.0
0.1
5.0
3.0
1.0
4.0
미량
잔량-
-
2.0
2.2
1.5
1.0
1.5
0.6
1.0
3.0
5.0
5.0
1.0
0.1
5.0
3.0
1.0
4.0
a very small amount
Balance
5.0
2.0
2.2
1.5
1.0
1.5
0.6
1.0
3.0
5.0
5.0
1.0
0.1
5.0
3.0
1.0
4.0
미량
잔량-
5.0
2.0
2.2
1.5
1.0
1.5
0.6
1.0
3.0
5.0
5.0
1.0
0.1
5.0
3.0
1.0
4.0
a very small amount
Balance
[[ 처방예Prescription example 5: 5: 맛사지Massage 크림] cream]
화장료의 일 예로서, 제조예 2의 아마씨 점액 추출물을 함유한 맛사지 크림을 처방하였는데, 처방예는 하기 표 7과 같았다.As an example of a cosmetic preparation, a massage cream containing the extract of flaxseed mucilage of Preparation Example 2 was used. The prescription examples were as shown in Table 7 below.
친유형 모노스테아린산 글리세린
스테아릴알콜
스테아린산
폴리솔베이트 60
솔비탄스테아레이트
이소스테아릴이소스테레이트
스쿠알란
광물유
디메치콘
히드록시에칠셀룰로오스
글리세린
트리에탄올아민
방부제, 향, 색소
증류수Flaxseed mucus extract
Pro-type glycerin monostearate
Stearyl alcohol
Stearic acid
Polysorbate 60
Sorbitan stearate
Isostearyl isoserate
Squalane
Mineral oil
Dimethicone
Hydroxyethyl cellulose
glycerin
Triethanolamine
Preservative, fragrance, pigment
Distilled water
1.5
1.5
1.0
1.5
0.6
5.0
5.0
35.0
0.5
0.12
6.0
0.7
미량
잔량45.0
1.5
1.5
1.0
1.5
0.6
5.0
5.0
35.0
0.5
0.12
6.0
0.7
a very small amount
Balance
[[ 처방예Prescription example 6: 에센스] 6: Essence]
화장료의 일 예로서, 제조예 2의 아마씨 점액 추출물을 함유한 에센스를 처방하였는데, 처방예는 다음 표 8과 같았다.As an example of the cosmetic material, an essence containing the extract of flaxseed mucilage of Preparation Example 2 was prescribed, and the prescription examples were as shown in Table 8 below.
글리세린
베타인
피이지 1500
알란토인
DL-판테놀
이.디.티.에이-2Na
벤조페논 - 9
히드록시에칠 셀룰로오스
소듐히아루로네이트
카르복시비닐폴리머
트리에탄올아민
옥틸도데칸올
옥틸도데세스 -16
에탄올
방부제, 향, 색소
증류수Flaxseed mucus extract
glycerin
Betaine
PIZZY 1500
Allantoin
DL-Panthenol
Lee D. T.-2Na
Benzophenone-9
Hydroxyethyl cellulose
Sodium hyaruronate
Carboxyvinyl polymer
Triethanolamine
Octyldodecanol
Octyldodec-16
ethanol
Preservative, fragrance, pigment
Distilled water
10.0
5.0
2.0
0.1
0.3
0.02
0.04
0.1
8.0
0.2
0.18
0.3
0.4
6.0
미량
잔량70.0
10.0
5.0
2.0
0.1
0.3
0.02
0.04
0.1
8.0
0.2
0.18
0.3
0.4
6.0
a very small amount
Balance
[[ 처방예Prescription example 7: 팩] 7: Pack]
화장료의 일 예로서, 제조예 2의 아마씨 점액 추출물을 함유한 팩을 처방하였는데, 처방예는 하기 표 9와 같았다.As an example of the cosmetic, a pack containing the flaxseed mucilage extract of Production Example 2 was prescribed, and the prescription examples were as shown in Table 9 below.
폴리비닐알콜
셀룰로오스 검
글리세린
피이지1500
사이크로데스트린
DL - 판테놀
알란토인
글리시리진산모노암모늄
니코틴아미드
에탄올
피이지 40 경화피마자유
향, 색소, 방부제
증류수Flaxseed mucus extract
Polyvinyl alcohol
Cellulose sword
glycerin
PIZZY 1500
Cyclostristin
DL - Panthenol
Allantoin
Monoammonium glycyrrhizin acid
Nicotinamide
ethanol
FYGEN 40 Hardened castor oil
Fragrance, coloring, preservative
Distilled water
15.0
0.15
3.0
2.0
0.15
0.4
0.1
0.3
0.5
6.0
0.3
미량
잔량10.0
15.0
0.15
3.0
2.0
0.15
0.4
0.1
0.3
0.5
6.0
0.3
a very small amount
Balance
[[ 실험예Experimental Example 2: 피부 장벽기능 회복 효과] 2: Skin barrier function recovery effect]
본 발명의 아마씨 점액추출물을 함유하는 화장료의 피부 장벽기능 회복 효과를 알아보기 위하여 다음과 같이 실험을 실시하였다. In order to examine the skin barrier function recovery effect of cosmetics containing the extract of flaxseed mucus of the present invention, the following experiment was conducted.
실험은 사람의 상박에 Taping stripping Method를 이용하여 피부의 장벽을 손상시킨 후, 표피 수분 손실량(TEWL,transdermal water loss)을 servomed사(스웨덴) evaporimeter EP1으로 측정하여 4.0g/㎡/h에 도달하면, 상기 처방예 4에서 제조한, 본 발명의 아마씨 점액추출물을 함유하는 실시예 1, 비교예 1~2의 영양크림을 각각을 5㎠ 면적에 도포한 후, 표피 수분 손실량을 1시간, 2시간, 4시간, 8시간 경과 후에 측정하여 감소되는 정도를 평가함으로써 장벽기능이 회복되는 정도를 평가하였다. 이때, 공지의 지질혼합물(ceramide :cholesterol : fatty acid의 2:1:1 혼합물)을 양성 대조군으로 사용하였다. 결과는 초기 손상된 장벽 상태에서의 표피 수분 손실량을 기준(100%)으로 하여 시간에 따른 변화를 비교한 후, 하기 표 10에 나타내었다.Experiments were carried out by using a taping stripping method to damage the skin barrier and measuring the skin water loss (TEWL, transdermal water loss) to 4.0 g / m 2 / h measured by servomed (Sweden) evaporimeter EP 1 , The nutritional creams of Example 1 and Comparative Examples 1 and 2 containing the flaxseed mucilage extract of the present invention prepared in the aforementioned Prescription Example 4 were applied to an area of 5 cm 2 and the skin moisture loss was measured for 1 hour and 2 hours , 4 hours, and 8 hours after the administration, and evaluated for the extent to which the barrier function was restored. At this time, a known lipid mixture (ceramide: 2: 1: 1 mixture of cholesterol: fatty acid) was used as a positive control. The results are shown in Table 10 below, with changes in moisture content of the skin in the initial damaged barrier state being taken as a reference (100%) and compared with time.
상기 표 10의 결과에서 보는 바와 같이, 본 발명의 아마씨 점액추출물을 함유하는 화장료인 실시예 1의 경우, 비교예 1~2에 비하여 피부 장벽기능 회복 효과가 매우 우수함을 확인할 수 있었다.
As shown in the results of Table 10, it was confirmed that the skin barrier function recovery effect of Example 1, which is a cosmetic containing the extract of flaxseed mucilage of the present invention, is superior to those of Comparative Examples 1 and 2.
[[ 실험예Experimental Example 3: 피부 3: Skin 보습력Moisture power 개선효과] Improvement effect]
본 발명의 아마씨 점액추출물을 함유하는 화장료의 피부 보습력 개선효과를 알아보기 위하여 다음과 같이 실험을 실시하였다. 피부 질환이 없는 20~40대 25명을 대상으로 1조 당 20명 씩 2개조로 나누고, 각 조별로 상기 처방예 4에서 제조한, 아마씨 점액추출물을 함유하는 실시예 1와 비교예 1~2의 영양크림을 매일 2회씩 1개월간 얼굴 및 전박부에 도포하게 하였다. In order to examine the skin moisturizing effect of the cosmetic composition containing the extract of flaxseed mucus of the present invention, the following experiment was conducted. Twenty-five to twenty-four patients without skin disease were divided into two groups of twenty persons per one group. In each group, Example 1 and Comparative Examples 1 to 2, which contained the flaxseed mucus extract prepared in the above-mentioned Prescription Example 4 Of the nutritional cream was applied to the face and forehead twice a day for one month.
도포 시작 전 항온, 항습 조건(24℃, 습도 40%)에서 corneometer(CM820 courage Khazaka electronic GmbH, Germany)를 이용하여 피부 전도도를 미리 측정하여 기본 값을 삼고, 1주, 2주, 4주 경과 후의 피부 전도도 증가율(%)을 측정하여 평가하였다. 결과를 하기 표 11에 나타내었다.The skin conductivity was measured in advance using a corneometer (CM820 courage Khazaka electronic GmbH, Germany) under the constant temperature and humidity conditions (24 ° C, 40% humidity) before the start of application and the values were measured at 1 week, 2 weeks, The skin conductivity increase rate (%) was measured and evaluated. The results are shown in Table 11 below.
상기 표 11의 결과에서 보는 바와 같이, 본 발명의 아마씨 점액추출물을 함유하는 화장료인 실시예 1의 경우, 비교예 1~2에 비하여 피부 전도도 증가율이 매우 우수하였다. 일반적으로 피부 전도도는 피부 수분량에 비례하므로, 상기의 결과로부터 본 발명에 아마씨 점액추출물을 함유하는 화장료는 그렇지 않은 화장료에 비해 피부 수분 함량도 높게 유지한다는 것을 확인할 수 있다. As shown in the results of Table 11, in Example 1, which is a cosmetic containing the extract of flaxseed mushroom of the present invention, the rate of skin conductivity increase was much higher than those of Comparative Examples 1 and 2. In general, the skin conductivity is proportional to the skin moisture content. From the above results, it can be seen that the cosmetic composition containing the extract of flaxseed extract in the present invention keeps the skin moisture content higher than that of the non-cosmetic ingredients.
따라서, 본 발명의 아마씨 점액추출물을 함유하는 화장료는 피부 보습력 개선 효과가 탁월함을 알 수 있었다.
Therefore, it was found that the cosmetic composition containing the extract of flaxseed mucus of the present invention is excellent in improving the skin moisturizing ability.
[[ 실험예Experimental Example 4: 4: 사용감Feeling 개선 효과 평가] Evaluation of improvement effect]
사용감 개선 효과 평가는 다음과 같이 실시하였다. 20명의 30~40세 여성을 무작위로 2개군으로 나누어 실시예 1과 비교예 2의 영양크림을 매일 아침 저녁 2회씩 세안 후 적당량을 눈가를 중심으로 연속적으로 바르게 하였다. 이후, 각 피검자의 사용감을 사용자 설문을 통하여 평가하였다. 측정하고자 하는 파라미터(발림성, 끈적임, 쿠션감, 유연감, 밀착성)의 특성에 따라 1~10점을 부여하도록 하였다. 이때, 해당 특성이 낮으면 1점 쪽, 높으면 10점 쪽을 부여하도록 하였다. Evaluation of feeling improvement effect was carried out as follows. Twenty women between the ages of 30 and 40 were randomly divided into two groups, and the nutritional creams of Example 1 and Comparative Example 2 were washed twice daily in the morning and evening, and then an appropriate amount was continuously and centered around the eyes. After that, the feeling of each subject was evaluated through a user questionnaire. 1 to 10 points were given depending on the characteristics of the parameters to be measured (wetting, stickiness, cushioning, anesthesia, and adhesion). At this time, if the characteristic is low, one point is given to the one point and the high point is given to the ten point.
실험 결과는 하기의 표 12에 나타낸 바와 같았다. 각각의 평가 항목을 10점 만점으로 하여 평가를 하였으며, 표 12와 같은 결과를 얻었다. The experimental results are shown in Table 12 below. Each evaluation item was rated on a scale of 10, and the results as shown in Table 12 were obtained.
상기 표 12의 결과에서 보듯이, 아마씨 점액 추출물을 함유한 본 발명의 크림은 화장품에 보습제와 사용감개선제로 통상적으로 광범위하게 사용하는 1,3-부틸렌글라이콜을 사용한 비교예 2과 비교하면, 발림성, 쿠션감, 유연감, 밀착성이 우수하여 화장품 사용감이 월등히 우수함을 나타냈으며, 끈적임이 매우 적은 것을 확인 할 수 있었다.As can be seen from the results of Table 12, the cream of the present invention containing the extract of flaxseed mushroom extract, as compared with Comparative Example 2 using 1,3-butylene glycol, which is widely used as a moisturizer and a feeling- It was found that the feeling of feeling of using cosmetics was excellent, and the stickiness was very small.
따라서, 본 발명의 아마씨 점액 추출물은 화장품의 사용감 개선제로서, 매우 뛰어난 효과를 갖는 것을 확인할 수 있었다.
Therefore, it was confirmed that the extract of the present invention of flaxseed mushroom has an excellent effect as a feeling-of-use improving agent for cosmetics.
[[ 실험예Experimental Example 5: 설문조사] 5: Survey]
본 발명의 아마씨 점액 추출물을 함유하는 화장료의 피부 보습력 개선효과를 알아보기 위하여 다음과 같이 실험을 실시하였다. 피부 질환이 없는 20~40대 25명을 대상으로 1조 당 20명 씩 2개조로 나누어, 각 조별로 처방예 4에서 제조한, 아마씨 점액 추출물을 함유하는 실시예 1의 영양크림 및 비교예 1~2의 영양크림을 매일 2회씩 1개월간 얼굴 및 전박부에 도포하게 하였다. In order to examine the skin moisturizing effect of the cosmetic composition containing the extract of flaxseed mucilage of the present invention, the following experiment was conducted. The nutritional cream of Example 1 and Comparative Example 1 containing the flaxseed mucilage extract prepared in Prescription Example 4 were divided into two groups of 20 persons per one group, 2 nutritional creams were applied to the face and forehead twice a day for one month.
시험대상자에 대하여 실시예 1과 비교예 1~2을 사용하고 난 후의 피부 당김, 거칠음, 탄력 변화에 대한 설문조사를 통하여 주관적인 효능 평가를 시행하였다. 설문조사는 피부 당김, 거칠음, 탄력 변화의 각 항목에 대하여 제품의 효과에 대한 만족도를 1~5점(숫자가 클수록 만족도 높음)으로 구분하여 표시하도록 하였으며, 그 결과를 하기 표 13에 나타내었다.Subjective efficacy was evaluated by questionnaire survey on skin pull, roughness, and elasticity change after using Example 1 and Comparative Examples 1 and 2 for the test subjects. The questionnaire was divided into 1 ~ 5 points (satisfaction with the higher number is satisfied) about the effect of the product on each item of skin pull, roughness, and elasticity change, and the results are shown in Table 13 below.
sample
상기 표 13의 결과에서 보는 바와 같이, 본 발명의 본 발명의 아마씨 점액추출물을 함유하는 화장료인 실시예 1의 경우, 비교예 1~2에 비하여 피부의 당김, 거칠음, 윤기를 개선하는 효과가 월등함을 알 수 있었다.As shown in the results of Table 13, in the case of Example 1, which is a cosmetic containing the extract of flaxseed mushroom of the present invention of the present invention, the effect of improving the pulling, roughness and gloss of the skin is superior to those of Comparative Examples 1 and 2 .
Claims (8)
사용감 개선, 피부보습, 피부 각질형성세포 분화 촉진 및 피부 장벽기능 회복을 위한 화장료 조성물.
Flaxseed mucilage or mucus extract as an active ingredient,
A cosmetic composition for improving feeling, skin moisturizing, promoting differentiation of skin keratinocyte, and restoring skin barrier function.
상기 아마씨 점액 또는 점액 추출물은,
화장료 조성물 총 중량에 대하여 0.001 내지 100.0중량% 함유되는 것을 특징으로 하는 화장료 조성물.
The method according to claim 1,
The flaxseed mucilage or mucus extract,
Is contained in an amount of 0.001 to 100.0% by weight based on the total weight of the cosmetic composition.
상기 아마씨 점액 추출물은,
(a) 물, 탄소수 1~4의 무수 또는 함수 저급 알코올, 아세톤, 에틸 아세테이트, 클로로포름, 부틸아세테이트 및 1,3-부틸렌 글리콜로 구성된 군으로부터 선택되는 추출용매를 아마씨에 가하여 추출한 점액추출물, (b) 초음파를 아마씨에 가하여 추출한 점액추출물 및 (c) 초임계 용매를 아마씨에 가하여 추출한 점액추출물 중 선택되는 어느 하나인 것을 특징으로 하는 화장료 조성물.
The method according to claim 1,
The above-mentioned flaxseed mucus extract,
(a) a mucilage extract obtained by extracting water with an extracting solvent selected from the group consisting of water, an anhydrous or a lower alcohol having 1 to 4 carbon atoms, acetone, ethyl acetate, chloroform, butyl acetate and 1,3-butylene glycol; (b) a mucus extract obtained by adding an ultrasonic wave to flaxseed extract, and (c) a mucus extract obtained by adding a supercritical solvent to flaxseed extract.
상기 화장료 조성물은,
수용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이로 구성된 군으로부터 선택되는 어느 하나의 제형인 것을 특징으로 하는 화장료 조성물.The method according to claim 1,
In the cosmetic composition,
Is any one selected from the group consisting of aqueous solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, soaps, surfactant-containing cleansers, oils, powder foundations, emulsion foundations, wax foundations and sprays ≪ / RTI >
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130053595A KR101440844B1 (en) | 2013-05-13 | 2013-05-13 | Cosmetic composition with Linum usitatissimum seed mucus or the extract of Linum usitatissimum seed mucus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130053595A KR101440844B1 (en) | 2013-05-13 | 2013-05-13 | Cosmetic composition with Linum usitatissimum seed mucus or the extract of Linum usitatissimum seed mucus |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101440844B1 true KR101440844B1 (en) | 2014-09-17 |
Family
ID=51760262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020130053595A KR101440844B1 (en) | 2013-05-13 | 2013-05-13 | Cosmetic composition with Linum usitatissimum seed mucus or the extract of Linum usitatissimum seed mucus |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101440844B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160107002A (en) * | 2015-03-03 | 2016-09-13 | 조계숙 | A method for preparing composition with flexseed |
CN115644442A (en) * | 2022-11-04 | 2023-01-31 | 肽源(广州)生物科技有限公司 | Salvia seed extract with effect of promoting proliferation of bifidobacteria and preparation method and application thereof |
WO2023041437A1 (en) * | 2021-09-14 | 2023-03-23 | Basf Se | An extract of linum usitatissimum seeds |
KR20240146812A (en) | 2023-03-30 | 2024-10-08 | 주식회사 엠앤코스 | Cosmetic composition for skin moisturizing and skin soothing containing fermented plant seeds extract |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993016707A1 (en) * | 1992-02-19 | 1993-09-02 | Smithkline Beecham Plc | Linseed mucilage |
KR20040084256A (en) * | 2003-03-27 | 2004-10-06 | 주식회사 태평양 | A composition of skin external application containing the IB complex composing Soybean Germ Isoflavone Agylcone, Pomegranate Extract and Secoisolariciresinol for improving skin wrinkle and enhancing elasticity |
-
2013
- 2013-05-13 KR KR1020130053595A patent/KR101440844B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993016707A1 (en) * | 1992-02-19 | 1993-09-02 | Smithkline Beecham Plc | Linseed mucilage |
KR20040084256A (en) * | 2003-03-27 | 2004-10-06 | 주식회사 태평양 | A composition of skin external application containing the IB complex composing Soybean Germ Isoflavone Agylcone, Pomegranate Extract and Secoisolariciresinol for improving skin wrinkle and enhancing elasticity |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160107002A (en) * | 2015-03-03 | 2016-09-13 | 조계숙 | A method for preparing composition with flexseed |
KR101687899B1 (en) | 2015-03-03 | 2016-12-19 | 조계숙 | A method for preparing composition with flexseed |
WO2023041437A1 (en) * | 2021-09-14 | 2023-03-23 | Basf Se | An extract of linum usitatissimum seeds |
CN115644442A (en) * | 2022-11-04 | 2023-01-31 | 肽源(广州)生物科技有限公司 | Salvia seed extract with effect of promoting proliferation of bifidobacteria and preparation method and application thereof |
KR20240146812A (en) | 2023-03-30 | 2024-10-08 | 주식회사 엠앤코스 | Cosmetic composition for skin moisturizing and skin soothing containing fermented plant seeds extract |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101912478B1 (en) | Exopolysaccharide for the treatment and/or care of the skin, mucous membranes, hair and/or nails | |
KR102227355B1 (en) | Complex cosmetic composition for non-irritating weak acid exfoliation and epithelial cell nutrition | |
KR101440844B1 (en) | Cosmetic composition with Linum usitatissimum seed mucus or the extract of Linum usitatissimum seed mucus | |
KR100824212B1 (en) | Composition for skin protection containing placenta and its manufacturing method | |
KR20120000251A (en) | Cosmetic composition containing kelp extract | |
KR102189330B1 (en) | A cosmetic composition for skin improvement comprising bulb extract | |
KR102104214B1 (en) | Cosmetic composition comprising potassium alum | |
KR101803271B1 (en) | Cosmetic composition for moisturizing or improving skin elasticity | |
KR20190021083A (en) | Cosmetic composition comprising extract of Alpinia officinarum Hance as active ingredient | |
KR20150086922A (en) | Composition for relieving skin irritation and moisturizing skin containing natural fermented pine leaf extract | |
KR20150078868A (en) | Cosmetic composition containing ginsenoside Rd, Rb2 and Bambusae Caulis in Taeniam extracts | |
KR101870377B1 (en) | Cosmetic composition for improving moisturizing and antioxidant containing ultrasonicating extract of cucumber seed | |
JP6510744B2 (en) | Cosmetics | |
KR20110052095A (en) | Cosmetic composition for moisturizing skin containing mushroom extract | |
KR20090105222A (en) | Cosmetic composition for shrinking pores | |
KR101953676B1 (en) | Cosmetic composition for skin moisturizing containing ultrasonicating extract of harpagophytum procumbens | |
KR100946583B1 (en) | Cosmetic composition for skin moisturizing containing pine extract as active ingredient | |
KR101671269B1 (en) | Cosmetic composition with the extract of Tillandsia usneoides for skin moisturizing, keratinocyte differentiation enhancement and skin barrier function recovery | |
KR101009767B1 (en) | Cosmetic composition for exfoliation of skin containing papain and nopal extract | |
JPH11158054A (en) | Skin lotion | |
KR100532633B1 (en) | Cosmetic composition having anti-inflammatory, skin-protecting, skin-elastic effects which comprise mixed plants extract | |
KR102162377B1 (en) | Extracts derived from natural products and cosmetic composition containing the same, and process for producing the same | |
KR101557422B1 (en) | Cleansing composition and cosmetic composition with the extract of Styrax japonica | |
KR20190021114A (en) | Composition for anti-inflammation, inhibiting secretion of sebum, or treating acne on the skin comprising plant extract | |
KR101427027B1 (en) | A Skin External Composition Containing Callus Extract Derived from Chaenomeles Sinensis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20130513 |
|
PA0201 | Request for examination | ||
A302 | Request for accelerated examination | ||
PA0302 | Request for accelerated examination |
Patent event date: 20131219 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination Patent event date: 20130513 Patent event code: PA03021R01I Comment text: Patent Application |
|
N231 | Notification of change of applicant | ||
PN2301 | Change of applicant |
Patent event date: 20140117 Comment text: Notification of Change of Applicant Patent event code: PN23011R01D |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20140227 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20140719 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20140905 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20140905 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20210622 Start annual number: 8 End annual number: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20220608 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20230607 Start annual number: 10 End annual number: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20240612 Start annual number: 11 End annual number: 11 |